WebQTL
 
   |    Home    |    Search    |    Help    |    News    |    References    |    Policies    |    Links    |    Welcome! Login   

Data Set Group: Eye M430v2 modify this page

Data Set: Eye M430v2 (Sep08) RMA modify this page
GN Accession: GN207
GEO Series: No Geo series yet
Title: Gene expression landscape of the mammalian eye: A global survey and database of mRNAs of 103 varieties of mice
Organism: Mouse (mm10)
Group: BXD
Tissue: Eye mRNA
Dataset Status: Public
Platforms: Affy Mouse Genome 430 2.0 (GPL1261)
Normalization: RMA
Contact Information
Eldon Geisert
Emory Eye Center
B5600 Clinic B 1365B Clifton Road NE
Atlanta, GA 30322 USA
Tel. 404-778-4239
egeiser@emory.edu
Website
Download datasets and supplementary data files

Specifics of this Data Set:
None

Summary:

FINAL RECOMMENDED EYE DATA SET. The HEIMED September 2008 RMA data release provides estimates of gene expression in whole eyes of 103 lines of young adult mice generated using 221 Affymetrix M430 2.0 arrays. This data set is intended for exploration of the genetics and genomics of the mouse eye, retina, lens, retinal pigment epithelium, cornea, iris and choroid. Data were generated at UTHSC with support from a grant from Dr. Barrett Haik, Director of the Hamilton Eye Institute (HEI). We used pooled RNA samples, usually two independent pools--one male, one female pool--for most lines of mice. This data set was processed using the RMA protocol. A total of 2223 probes sets are associated with LRS values greater than 46 (LOD >10).

Users of these mouse eye data may also find the following complementary resources extremely useful:

  1. NEIBank collection of ESTs and SAGE data.
  2. RetNet: the Retinal Information Network--tables of genes and loci causing inherited retinal diseases
  3. Mouse Retina SAGE Library from the Cepko laboratory. This site provides extensive developmental data from as early as embryonic day E12.5.
  4. Digital reference of ophthalmology from Columbia provides high quality photographs of human ocular diseases, case studies, and short explanations. This reference does not have a molecular focus.
  5. Mouse Retinal Developmental Gene Expression data sets from the Friedlander laboratory. This site provides extensive developmental data using the Affymetrix U74 v 2 array (predecessor of the M430).
  6. Data sets on differential gene expression in anatomical compartments of the human eye from Pat Brown's lab. View expression signatures for different ocular tissues using the geneXplorer 2.0.


About the cases used to generate this set of data:

This is the complete and final HEIMED data set. HEIMED consists of expression data for 103 genetically defined lines of mice with standard errors of the mean. Almost all animals are young adults between 50 and 80 days of age (Table 1, maximum age is 123 days). We measured expression in conventional inbred strains, BXD recombinant inbred (RI) strains, reciprocal F1s between C57BL/6J and DBA/2J, and several mutant and knockout lines. We have combined all common strains, F1 hybrids, and mutants into a group called the Mouse Diversity Panel (MDP). Four lines, namely, C57BL/6J (B6), DBA/2J (D2), and the pair of B6D2F1 and D2B6F1 hybrids are common to both the MDP and the BXD set. This is a breakdown of cases that are part of HEIMED:

  1. 68 BXD strains. The first 32 of these strains are from the Taylor series of BXD strains generated at the Jackson Laboratory by Benjamin A. Taylor. BXD1 through BXD32 were started in the late 1970s, whereas BXD33 through 42 were started in the 1990s. Only one of these strains, BXD24 (know also known as BXD24b), has retinal degeneration (a spontaneous mutation). The other 36 BXD strains (BXD43 and higher) were bred by Lu Lu, Jeremy Peirce, Lee M. Silver, and Robert W. Williams starting in 1997 using B6D2 generation 10 advanced intercross progeny. This modified breeding protocol doubles the number of recombinations per BXD strain and improves mapping resolution (Peirce et al. 2004). All of the Taylor series of BXD strains and many of the new BXD strains are available from the Jackson Laboratory. All of the new BXD strains (BXD43 and higher) are also available directly from Lu Lu and colleagues at the University of Tennessee Health Science Center in Memphis, TN, USA.
  2. 35 MDP lines, including 26 inbred strains representing closely related substrains (e.g, BALB/cJ and BALB/cByJ), many of the most widely used common Mus musculus domesticus inbred strains (e.g., C57BL/6J and 129S1/SvImJ), inbred but wild-derived representatives of common subspecies (Mus musculus domesticus, e.g, WSB/EiJ; M. musculus musculus, e.g., CZECHII/EiJ; M. musculus molossinus, e.g., MOLF/EiJ; M. musculus castaneus, e.g., CAST/EiJ); and even one different species of mouse (Mus spicilegus, PANCEVO/EiJ). The MDP also includes the reciprocal F1 hybrids (B6D2F1 and D2B6F1) and the following 6 KO lines and the Nyx-nob mutant:
  3. 6 knockouts (KO), including a KO of Rpe65, and 5 DeltaGen Inc. knockout lines provided by Dr. Ted Choi. These KO lines have had a bacterial lacZ construct inserted into the gene. The endogenous promoter drives expression of beta-galactosidase. RT-PCR analysis detects a gene transcript in most tissues. The following KOs from DeltaGen were studied: Gabra1, Gabbr1, Gnb1, Gpr19, and Clcn3. We also included one spontaneous mutant of the nyctalopin (Nyx no b wave "nob") gene (Pardue et al., 1998) that is on a BALB/cByJ background.

Rod photoreceptor degeneration in inbred mice: Six strains of mice included in HEIMED suffer from severe loss of photoreceptors (mainly rods) and have the equivalent of night blindness in human patients. The death of photoreceptors in these strains occurs by one to two months of age and is often caused by the retinal degeneration 1 (rd1) mutant allele in the rod cyclic-GMP phosphodiesterase 6 beta subunit gene (Pde6b). The following strains are known to have photoreceptor degeneration: C3H/HeJ, FVB/NJ, MOLF/EiJ, SJL/J and BXD24/TyJ. BXD24/TyJ is now known as BXD24b/TyJ and has nearly complete retinal degeneration. BXD24a/TyJ, a 1988 F80 inbred stock that has been rederived from cryogenic storage, does not have retinal degeneration (stock number 005243) and is an ideal coisogenic control, but is not included in the HEIMED data set.

As expected (Dickerson LW et al., 2002) and as judged from the absence of rhodopsin expression, one of the DeltaGen KO lines (chloride ion channel 3, Clcn3) also has retinal degeneration: B6129P2F2N1-Clcn3. Degeneration in this strain is likely to include all rods and all cones. The cone defect is obvious from the decrease in expression of Gnat2, a gene associated with cones and achromatopsia in mice and humans.

Lines of mice were selected using the following criteria:

  • genetic and phenotypic diversity, including use by the Phenome Project
  • representation of a fairly wide variety of different subspecies of Mus
  • their use in making genetic reference populations including recombinant inbred strains, cosomic strains, congenic and recombinant congenic strains
  • their use by the Complex Trait Consortium to make the Collaborative Cross (Tel Aviv/Wellcome, Oak Ridge/DOE, and Perth/UWA)
  • genome sequence data from three sources (NHGRI, Celera, and Perlegen-NIEHS)
  • interesting mutations or knockouts affecting genes with high expression in the eye
  • general availability from The Jackson Laboratory. The only exception are the DeltaGen KO mice.

We have included all eight parents of the Collaborative Cross (129S1/SvImJ, A/J, C57BL/6J, CAST/EiJ, NOD/LtJ, NZO/HlLtJ, PWK/PhJ, and WSB/EiJ) in the MDP. Fourteen MDP strains have been partially sequenced by Perlegen for the NIEHS, including including 129S1/SvImJ, A/J, AKR/J, BALB/cByJ, C3H/HeJ, CAST/EiJ, DBA/2J, FVB/NJ, KK/HlJ, MOLF/EiJ, NOD/LtJ, NZW/LacJ, PWD/PhJ, and WSB/EiJ (see the GeneNetwork SNP Browser for data, details, and see Perlegen's excellent data resources and browser).

  1. 129S1/SvImJ : Collaborative Cross strain sequenced by NIEHS; background for many knockouts (R1 ES cell line); Phenome Project A list. This strain (JAX No 002448, aka 129S1/Sv-++Kitl/+) carries hypopigmentation mutations (white bellied chinchilla) of the tyrosinase gene on Chr 7 and a mutant allele of the steel (Kitl) gene. It is also a cone photoreceptor function loss 3 mutant (Cpfl3 allele) of the Gnat2 gene that is a model for achromatopsia (JAX Stock Number: 002448)
  2. A/J: Collaborative Cross strain sequenced by Perlegen/NIEHS; parent of the AXB/BXA panel. A tyrosinase (Tyr c allele) albino mutant. This strain is particularly sensitive to light-induced photoreceptor loss (Danciger et al., 2007). (JAX Stock Number: 000646)
  3. BALB/cByJ: Sequenced by NIEHS; maternal parent of the CXB panel; Phenome Project old group A list. A tyrosinase (Tyr c allele) albino mutant and also a tyrosinase related protein 1 (Tyrp1 b) brown allele mutant. Small brain, not aggressive (JAX Stock Number: 001026)
  4. BALB/cJ: Phenome Project A list. A tyrosinase (Tyr c allele) albino mutant and also a tyrosinase related protein 1 (Tyrp1 b) brown allele mutant. Large brain and aggressive (JAX Stock Number: 000651)
  5. BXSB/MpJ: A white-bellied agouti strains with interesting autoimmune disease restricted to males that is associated with a mutation in the Yaa gene that causes glomerulonephritis, a dramatic increase in number of peripheral monocytes, and pre-B-cell deficiency (JAX Stock Number: 000740)
  6. C3H/HeJ: The Heston (He) substrain with a wildtype agouti (A allele) coat color. Sequenced by Perlegen/NIEHS; paternal parent of the BXH panel; Phenome Project old group A list. Important to note for this eye expression dataset, C3H/HeJ is a Pdeb6 rd1 mutant with near total photoreceptor loss at as early as postnatal day 30. Also a Tlr4 mutant that is endotoxin resistant. (JAX Stock Number: 000659)
  7. C57BL/6J: Sequenced by NIH/NHGRI; parental strain of AXB/BXA, BXD, and BXH; Phenome Project A list. Single most widely used inbred strain of mouse. (JAX Stock Number: 000664)
  8. C57BLKS/J: Black Kaliss strain (non-agouti a allele) derived from C57BL/6J, but genetically contaminated at some point mainly with DBA/2J and then reinbred. Now at the Jackson Laboratory. (JAX Stock Number: 000662)
  9. CAST/EiJ: A wild-derived inbred Mus musculus castaneus strain. Samples of this subspecies were captured in Southeast Asia. One of three wild-derived strains in the Collaborative Cross sequenced by NIEHS; Phenome Project A list. CAST/Ei and CAST/EiJ are the same strain. The addition of the "J" is trivial and was added when stock were transferred from Dr. Eicher's lab to the Jackson Laboratory production facility in about 2004. (JAX Stock Number: 000928)
  10. CBA/CaJ: Agouti strain from the Jackson Laboratory. Wildtype pigment genes. (JAX Stock Number: 000654)
  11. CZECHII/EiJ: Czech 2 is a wild-derived inbred strain M. musculus musculus strain. Samples of this subspecies were caught in the Czech Republic and inbred at the Jackson Laboratory by Eva Eicher. White-bellied agouti. (JAX Stock Number: 001144).
  12. DBA/2J: The dilute, brown, agouti (dba) strain is the oldest inbred strain of mouse. Inbreeding was started in 1909 by Little. A tyrosinase related protein 1 (Tyrp1 b) brown allele mutant. A myosin 5a (Myo5a d) dilute allele mutant. Sequenced by Perlegen/NIEHS and Celera; paternal parent of the BXD panel; Phenome Project old A group list. (JAX Stock Number: 000671)
  13. FVB/NJ: Friend's leukemia virus B (FVB) strain. Sequenced by Perlegen/NIEHS and Celera. Tyr c locus albino and a Pdeb6 rd1 mutant derived from Swiss mice at NIH. This has been the most common strain used to make transgenic mice due to large and easily injected oocytes; Phenome Project A list (JAX Stock Number: 001800).
  14. KK/HlJ: K Kondo's (KK) Kasukabe strain is a homozygous age-related hearing loss (ahl) allele mutant of the Cdh23 gene. A Tyr c locus albino strain. Males have a form of type 2 diabetes. Sequenced by Perlegen/NIEHS. (JAX Stock Number: 002106)
  15. LG/J: Large (LG) strain. Paternal parent of the Large-by-Small set of RI strains made by James Cheverud and colleagues (the LGXSM panel, not to be confused with the LongXShort or LXS panel). A Tyr c locus albino strain. (JAX Stock Number: 000675)
  16. LP/J: White-bellied agouit strain with a piebald mutation in the endothelin receptor type B Ednrb gene from at the Jackson Laboratory. Some reduction in melanocytes in choroid of eye due to neural creast migration abnormalities. (JAX Stock Number: 000676)
  17. MOLF/EiJ: A wild-derived inbred strain derived from M. musculus molossinus samples camputered in Fukuoka, Japan. This strain has the retinal degeneration rd1 allele in Pde6b. There appears to have been some genetic contamination of this strain with conventional inbred strains in the past several decades (F. Pardo, personal communication to RWW, August 2006). However, the strain is currently fully inbred. (JAX Stock Number: 000550)
  18. NOD/LtJ: Non-obese diabetic strain, originally from M. Hattori in Kyoto, Japan. This is the Edward Leiter (Lt) substrain from the Jackson Laboratory. Collaborative Cross strain sequenced by NIEHS; Phenome Project B list. Homozygous age-related hearing loss (ahl) allele mutant of the Cdh23 gene. A Tyr c locus albino strain. (JAX Stock Number: 001976)
  19. NZO/HlLtJ: New Zealand Obese strain. This is a severely obese and hypertensive strain. Males often develop a type 2 diabetes. Collaborative Cross strain. Agouti coat color. (JAX Stock Number: 002105)
  20. NZB/BlNJ: New Zealand Black inbred strain from Bielschowsky (BL, substrain is "B lowercase L N", not "BiN") now maintained at the Jackson Laboratory. (JAX Stock Number: 000648)
  21. NZW/LacJ: New Zealand White strain from the Laboratory Animal Center (Carshalton, UK), now maintained at the Jackson Laboratory. Carries the Tyr c locus albino mutation, the pink-eye dilution mutation in the Oca2 or p locus, and the brown allele at Tyrp1. (JAX Stock Number: 001058)
  22. PANCEVO/EiJ: PANCEVO/EiJ is a wild-derived inbred strain from the Mus spicilegus samples caught in the Pancevo, Serbia. This species of mouse is also known as the Steppe mouse (taxon identifier 10103). M. spicilegus is a colonial mound-building species. No known ocular or retina mutations, but the expression level of Gnat2 is low in this strain, either due to a 3' UTR length variant or possible achromatosia (cone degeneration) (JAX Stock Number: 001384)
  23. PWD/PhJ: A wild-derived Mus musculus musculus agouti strain inbred from samples caught near Prague, Czech Republic. Sequenced by Perlegen/NIEHS; parental strain for a consomic set by Forjet and colleagues. (JAX Stock Number: 004660)
  24. PWK/PhJ: A wild-derived Mus musculus musculus inbred strain from samples caught near Lhotka, Czech Republic. Collaborative Cross strain; Phenome Project D list. (JAX Stock Number: 003715)
  25. SJL/J: Swiss Webster inbred strain from Jim Lambert's lab at the Jackson Laboratory. This strain has the retinal degeneration rd1 allele in Pde6b. It also carries both the Tyr c albino mutation and the pink-eye dilution mutation in the Oca2 or p locus. Highly aggressive males. (JAX Stock Number: 000686)
  26. WSB/EiJ: Watkin Star line B (or "wild son-of-a-bitch") is a wild-derived Mus musculus domesticus inbred strain from samples caught in Maryland, USA. A Collaborative Cross strain sequenced by NIEHS; Phenome Project C list (JAX Stock Number: 001145)
  27. B6D2F1 and D2B6F1 (also listed as BDF1 and DBF1 in some graphs and tables): F1 hybrids generated by crossing C57BL/6J with DBA/2J. These black reciprocal F1 can be used to detect dominance effects. Comparison of the two reciprocal F1s can be used to detect parental origin (imprinting) effects. The D2B6F1 animals are currently available from the Jackson Laboratory as a special order.) (JAX Stock Number for B6D2F1 hybrids obtained from the Jackson Laboratory, aka B6D2F1/J 100006)

Most of the common inbred strains harbor mutations in genes the control pigmentation (Silvers, 2008 and material above in this INFO file). These gene include the albino and chinchilla alleles of the tyrosinase gene (Tyr, or human OCA1), the brown allele of the tyrosinase related protein 1 (Tyrp1), the pink-eye dilution allele of Oca2 (probe set 1418211), the non-agouti (black) and white-bellied alleles of the agouti signaling protein Asip, the steel allele of Kitlg, the dilute allele of Myo5a (probe set 1419754), and the piebald allele of Ednrb. In some of these cases, effects of the mutation are easily detected at the transcript level (Tyrp1, Oca2, and Myo5a), but in the other cases (Tyr, Asip, Ednrb, and Kitlg), mutations do not leave a strong imprint on expression.



About the tissue used to generate this set of data:

Tissue preparation protocol. Animal were killed by rapid cervical dislocation. Eyes were removed immediately and placed in RNAlater at room temperature. Usually six eyes from animals with a common sex, age, and strain were stored in a single tube.

Each array was hybridized with a pool of cRNA from 4 to 8 eyes from 2 to 4 animals. RNA was extracted at UTHSC by Zhiping Jia. If tissue was saved for RNA extraction at a later time, eyes were placed directly in RNAlater (Ambion, Inc.) and treated per the manufacturer’s directions. If eyes were used for immediate RNA extraction then we proceeded immediately to the next steps.

Dissecting and preparing eyes for RNA extraction

  1. Place eyes for RNA extraction in RNA STAT-60 (Tel-Test Inc.) and process per manufacturer’s instructions (in brief form below).
  2. Store RNA in 75% ethanol at –80 deg. C until use.

Total RNA was extracted with RNA STAT-60 (Tel-Test Inc.) according to the manufacturer's instructions. Briefly we:

  1. homogenize tissue samples in the RNA STAT-60 (1 ml/50 to 100 mg tissue)
  2. allowed the homogenate to stand for 5 min at room temperature
  3. added 0.2 ml of chloroform per 1 ml RNA STAT-60
  4. shook the sample vigorously for 15 sec and let the sample sit at room temperature for 3 min
  5. centrifuged at 12,000 G for 15 min
  6. transfered the aqueous phase to a fresh tube
  7. added 0.5 ml of isopropanol per 1 ml RNA STAT-60
  8. vortexed and allowed sample to stand at room temperature for 5-10 min
  9. centrifuged at 12,000 G for 10-15 min
  10. removed the supernatant and washed the RNA pellet with 75% ethanol
  11. stored the pellet in 75% ethanol at -80 deg C until use

Sample Processing. All samples were processed in the VA Medical Center, Memphis, Rheumatology Disease Research Core Center led by Dr. Weikuan Gu. All arrays were processed by Dr. Yan Jiao. In brief, samples were purified using a standard sodium acetate in alcohol method (recommended by Affymetrix). The RNA quality was checked using a 1% agarose gel. The 18S and 28S bands had to be clear and the 28S band had to be more prominent. RNA concentation was measured using a spectrophotometer. The 260/280 ratios had to be greater than 1.7, and the majority were 1.8 or higher. We used a total of 8 micrograms of RNA as starting amount for cDNA synthesis using a standard Eberwine T7 polymerase method (Superscript II RT, Invitrogen Inc., Affy Part No 900431, GeneChip Expression 3' Amplification One-Cyle cDNA Synthesis Kit). The Affymetrix IVT labeling kit (Affy 900449) was used to generate labeled cRNA. At this point the cRNA was evaluated again using both the 260/280 ratio (values of 2.0 or above were acceptable) and 1% agarose gel inspection of the product (a size range from 200 to 7000 bp is considered suitable for use). We used 45 micrograms of labeled cRNA for fragmentation. Those samples that passed both QC steps (<10% usually fail) were then sheared using a fragmentation buffer included in the Affymetrix GeneChip Sample Cleanup Module (Part No.900371). After fragmentation, samples were either stored at -80 deg. C until use (roughly one third) or were used immediately for hybridization.

Dealing with ocular pigmentation: Variable ocular pigmentation is a potential confound in a study of the whole eye transcriptome. Even the most careful RNA preparations taken from brown and beige colored mice tend to have faint residual pigmentation that affects hybridization signal. To address this problem, Dr. Yan Jiao purified total RNA using the Qiagen RNeasy MinElute Cleanup Kit (Cat No. 74204) all four batches.

Replication, sex, and sample balance: Our goal was to obtain data for independent biological sample pools from both sexes for most lines of mice. The four batches of arrays included in this final data set, collectively represent a reasonably well balanced sample of males and females, in general without within-strain-by-sex replication. Two strains are represented by a single male sample pool (BXD29 and A/J). Four lines are represented by two or three male sample pools (all of the five DeltaGen KO line). The SJL/J may be a single mixed sex sample. Users can study possible sex effects by comparing any results of expression data to that of a surrogate measurement that summarizes the overall sex balance of HEIMED. To do this just compare your data to those of probe sets 1427262_at (Xist, high in females) and probe set 1426438_at (Ddx3y, high in males). These two sex-specific probes are quantitative surrogates for the sex balance in this data set.

Technical duplicates: One sample, highlighted in the tables below, is a technical duplicate. The pair of technical duplicates were both of high quality. For statistical analysis, they should be combined and treated as single biological sample.

Batch structure: This data set consists of four batches (Table 2, far right column). The final September 2008 data set consists of a total of 221 arrays and 220 independent samples.

  1. Batch 1: November 2005, n = 78 arrays original arrays of which 76 were accepted into this final data set.
  2. Batch 2: January 2006, n = 62 arrays of which 62 were accepted.
  3. Batch 3: August 2006, n = 39 arrays of which 36 were accepted. (These three batches, including some arrays that were eventually dropped from the final 2008 data set, were combined to form the September 2006 data set.)
  4. Batch 4: Summer 2008, n = 53 arrays of which 47 were accepted.

Table 1: HEIMED case IDs, including sample tube ID, strain, age, sex, and source of mice (see Table 2 for information on array quality control)

 

Index TubeID Group Strain Age Sex Source
1 R2595E.1 GDP 129S1/SvImJ 59 F UTHSC RW
2 R2533E.1 GDP 129S1/SvImJ 60 M UTHSC RW
3 R0754E.1 GDP A/J 60 M JAX
4 R4521E KO B6129P2F2N1-Clcn3 69 M TChoi_Deltagen
5 R4522E KO B6129P2F2N1-Clcn3 69 M TChoi_Deltagen
6 R4523E KO B6129P2F2N1-Clcn3 67 M TChoi_Deltagen
7 R4526E KO B6129P2F2N1-Gabbr1 16 F TChoi_Deltagen
8 R4509E KO B6129P2F2N1-Gabbr1 16 M TChoi_Deltagen
9 R4510E KO B6129P2F2N1-Gabbr1 19 M TChoi_Deltagen
10 R4511E KO B6129P2F2N1-Gabbr1 20 M TChoi_Deltagen
11 R4524E KO B6129P2F2N1-Gabbr1 19 M TChoi_Deltagen
12 R4525E KO B6129P2F2N1-Gabbr1 22 M TChoi_Deltagen
13 R4515E KO B6129P2F2N1-Gabra1 67 M TChoi_Deltagen
14 R4516E KO B6129P2F2N1-Gabra1 69 M TChoi_Deltagen
15 R4517E KO B6129P2F2N1-Gabra1 67 M TChoi_Deltagen
16 R4512E KO B6129P2F2N1-Gnb5 22 F TChoi_Deltagen
17 R4513E KO B6129P2F2N1-Gnb5 25 M TChoi_Deltagen
18 R4514E KO B6129P2F2N1-Gnb5 22 M TChoi_Deltagen
19 R4518E KO B6129P2F2N1-Gpr19 70 M TChoi_Deltagen
20 R4519E KO B6129P2F2N1-Gpr19 68 M TChoi_Deltagen
21 R2601E.1 GDP BXD B6D2F1 73 F UTHSC RW
22 R2602E.1 GDP BXD B6D2F1 73 M UTHSC RW
23 R1676E.1 GDP BALB/cByJ 83 F JAX
24 R1672E.1 GDP BALB/cByJ 83 M JAX
25 R4530E GDP BALB/cJ 66 F JAX
26 R4529E GDP BALB/cJ 66 M JAX
27 R2704E.2 BXD BXD1 59 F UTHSC RW
28 R2707E.3 BXD BXD1 59 M BIDMC GR
29 R1231E.2 BXD BXD2 64 F UTHSC RW
30 R2598E.1 BXD BXD2 61 M UTHSC RW
31 R2591E.1 BXD BXD5 60 F BIDMC GR
32 R2714E.2 BXD BXD5 58 M UTHSC RW
33 R2570E.1 BXD BXD6 65 F UTHSC RW
34 R2694E.2 BXD BXD6 58 M UTHSC RW
35 R2538E.1 BXD BXD8 77 F UTHSC RW
36 R2709E.2 BXD BXD8 61 M UTHSC RW
37 R2708E.2 BXD BXD9 60 F UTHSC RW
38 R2569E.1 BXD BXD9 67 M UTHSC RW
39 R2581E.1 BXD BXD11 65 F UTHSC RW
40 R2612E.2 BXD BXD11 70 M UTHSC RW
41 R2742E.2 BXD BXD12 71 F UTHSC RW
42 R2543E.1 BXD BXD12 63 M UTHSC RW
43 R2586E.1 BXD BXD13 60 F BIDMC GR
44 R877E.2 BXD BXD13 76 M UTHSC RW
45 R2557E.1 BXD BXD14 60 F BIDMC GR
46 R1128E.2 BXD BXD14 65 M UTHSC RW
47 R2701E.3 BXD BXD15 60 F BIDMC GR
48 R2716E.2 BXD BXD15 60 M UTHSC RW
49 R2711E.2 BXD BXD16 61 F UTHSC RW
50 R2567E.1 BXD BXD16 60 M BIDMC GR
51 R2720E.2 BXD BXD18 59 F UTHSC RW
52 R2559E.1 BXD BXD18 59 M BIDMC GR
53 R2560E.1 BXD BXD19 60 F BIDMC GR
54 R2713E.2 BXD BXD19 60 M UTHSC RW
55 R2584E.1 BXD BXD20 59 F BIDMC GR
56 R2731E.2 BXD BXD20 60 M UTHSC RW
57 R2702E.2 BXD BXD21 59 F UTHSC RW
58 R2541E2.1 BXD BXD21 61 M UTHSC RW
59 R2553E.1 BXD BXD22 58 F BIDMC GR
60 R2700E.2 BXD BXD22 59 M UTHSC RW
61 R2558E-2.1 BXD BXD23 60 F BIDMC GR
62 R1086E.2 BXD BXD23 55 M UTHSC RW
63 R2719E.2 BXD BXD24 123 F UTHSC RW
64 R2589E2.1 BXD BXD24 59 M BIDMC GR
65 R2573E-2.1 BXD BXD25 67 F UAB
66 R2683E.2 BXD BXD25 58 M UTHSC RW
67 R2703E.2 BXD BXD27 60 F UTHSC RW
68 R2729E.3 BXD BXD27 68 M UTHSC RW
69 R2562E.3 BXD BXD28 60 F BIDMC GR
70 R2721E.2 BXD BXD28 60 M UTHSC RW
71 R2561E.3 BXD BXD29 60 M BIDMC GR
72 R1258E.2 BXD BXD31 57 F UTHSC RW
73 R2597E.1 BXD BXD31 61 M BIDMC GR
74 R2563E.1 BXD BXD32 63 F UTHSC RW
75 R1216E.2 BXD BXD32 76 M UTHSC RW
76 R2542E.1 BXD BXD33 67 F UTHSC RW
77 R857E.2 BXD BXD33 77 M UTHSC RW
78 R1451E.2 BXD BXD34 61 F UTHSC RW
79 R2585E.1 BXD BXD34 60 M BIDMC GR
80 R2698E.3 BXD BXD36 58 F BIDMC GR
81 R2705E.3 BXD BXD36 57 M BIDMC GR
82 R2710E.2 BXD BXD38 55 F UTHSC RW
83 R2532E.1 BXD BXD38 62 M UTHSC RW
84 R2574E.1 BXD BXD39 70 F UTHSC RW
85 R2695E.2 BXD BXD39 59 M UTHSC RW
86 R2699E.2 BXD BXD40 59 F UTHSC RW
87 R2590E.1 BXD BXD40 60 M BIDMC GR
88 R2696E.2 BXD BXD42 58 F UTHSC RW
89 R2596E.1 BXD BXD42 59 M BIDMC GR
90 R994E.2 BXD BXD43 60 F UTHSC RW
91 R2607E.1 BXD BXD43 67 M UTHSC RW
92 R2594E.1 BXD BXD44 63 F UTHSC RW
93 R2610E.2 BXD BXD44 68 M UTHSC RW
94 R2732E.2 BXD BXD45 63 F UTHSC RW
95 R2592E.1 BXD BXD45 62 M UTHSC RW
96 R967E.2 BXD BXD48 64 F UTHSC RW
97 R2606E.1 BXD BXD48 78 M UTHSC RW
98 R2933E.3 BXD BXD50 61 F UTHSC RW
99 R2937E.3 BXD BXD50 61 M UTHSC RW
100 R2603E.1 BXD BXD51 66 F UTHSC RW
101 R1042E.2 BXD BXD51 62 M UTHSC RW
102 R2980E.3 BXD BXD55 76 F UTHSC RW
103 R2690E.2 BXD BXD55 65 M UTHSC RW
104 R4176E BXD BXD56 67 F UTHSC RW
105 R4175E BXD BXD56 53 M UTHSC RW
106 R1006E.3 BXD BXD60 60 F UTHSC RW
107 R2725E.2 BXD BXD60 61 F UTHSC RW
108 R1074E.3 BXD BXD60 59 M UTHSC RW
109 R2534E2.1 BXD BXD61 70 F UTHSC RW
110 R2684E.2 BXD BXD61 62 M UTHSC RW
111 R1107E.3 BXD BXD62 54 F UTHSC RW
112 R2681E.2 BXD BXD62 62 M UTHSC RW
113 R965E.3 BXD BXD62 54 M UTHSC RW
114 R1425E.2 BXD BXD63 61 F UTHSC RW
115 R2576E.3 BXD BXD63 70 M UTHSC RW
116 R943E-2.2 BXD BXD64 56 F UTHSC RW
117 R2611E.1 BXD BXD64 68 M UTHSC RW
118 R2689E.2 BXD BXD65 63 F UTHSC RW
119 R2583E.1 BXD BXD65 60 M UTHSC RW
120 R2728E.2 BXD BXD66 67 F UTHSC RW
121 R2536E2.1 BXD BXD66 64 F UTHSC RW
122 R1207E.2 BXD BXD66 83 M UTHSC RW
123 R1192E.2 BXD BXD67 64 F UTHSC RW
124 R2727E.3 BXD BXD67 65 F UTHSC RW
125 R2691E.3 BXD BXD67 65 M UTHSC RW
126 R2551E.1 BXD BXD68 67 F UTHSC RW
127 R2726E.2 BXD BXD68 64 M UTHSC RW
128 R2593E.1 BXD BXD69 59 F UTHSC RW
129 R975E.2 BXD BXD70 64 F UTHSC RW
130 R2537E2.1 BXD BXD70 59 M UTHSC RW
131 R4531E BXD BXD71 87 F UTHSC RW
132 R4532E BXD BXD71 86 M UTHSC RW
133 R2779E.2 BXD BXD73 64 F UTHSC RW
134 R3024E.3 BXD BXD73 54 M UTHSC RW
135 R2565E.1 BXD BXD75 61 F UTHSC RW
136 R1397E-re.2 BXD BXD75 58 M UTHSC RW
137 R2687E.3 BXD BXD77 60 F UTHSC RW
138 R2717E.2 BXD BXD77 107 M UTHSC RW
139 R1421E.3 BXD BXD77 62 M UTHSC RW
140 R2579E.1 BXD BXD80 65 F UTHSC RW
141 R2686E.2 BXD BXD80 61 M UTHSC RW
142 R2956E.3 BXD BXD83 58 F UTHSC RW
143 R2960E.3 BXD BXD83 58 M UTHSC RW
144 R2922E.3 BXD BXD84 61 F UTHSC RW
145 R2895E.3 BXD BXD84 67 M UTHSC RW
146 R2692E.2 BXD BXD85 63 F UTHSC RW
147 R2715E.2 BXD BXD85 91 M UTHSC RW
148 R1405E.2 BXD BXD86 58 F UTHSC RW
149 R1225E.3 BXD BXD86 58 M UTHSC RW
150 R2724E.2 BXD BXD87 63 F UTHSC RW
151 R2540E.1 BXD BXD87 63 M UTHSC RW
152 R1433E.2 BXD BXD89 63 F UTHSC RW
153 R2546E.1 BXD BXD89 66 M UTHSC RW
154 R2578E2.1 BXD BXD90 61 F UTHSC RW
155 R859E.2 BXD BXD90 72 M UTHSC RW
156 R2682E.2 BXD BXD92 66 F UTHSC RW
157 R1388E.3 BXD BXD92 62 F UTHSC RW
158 R1322E.3 BXD BXD92 55 M UTHSC RW
159 R2733E.2 BXD BXD96 67 F UTHSC RW
160 R2554E.1 BXD BXD96 67 M UTHSC RW
161 R2649E.2 BXD BXD97 74 F UTHSC RW
162 R2577E.1 BXD BXD97 55 M UTHSC RW
163 R2645E.3 BXD BXD98 66 F UTHSC RW
164 R2688E.2 BXD BXD98 67 M UTHSC RW
165 R4533E BXD BXD99 80 F UTHSC RW
166 R4534E BXD BXD99 91 M UTHSC RW
167 R2885E.3 GDP BXSB/MpJ 61 F BIDMC GR
168 R2883E.3 GDP BXSB/MpJ 61 M BIDMC GR
169 R1700E.1 GDP C3H/HeJ 83 F UTHSC RW
170 R1704E.1 GDP C3H/HeJ 83 M UTHSC RW
171 R2605E.1 GDP BXD C57BL/6J 79 F UTHSC RW
172 R0871E GDP BXD C57BL/6J 65 F UTHSC RW
173 R0872E.1 GDP BXD C57BL/6J 66 M UTHSC RW
174 R0872E GDP BXD C57BL/6J 66 M UTHSC RW
175 R4507E KO C57BL/6J-Nyx 57 M Geisert
176 R4508E KO C57BL/6J-Nyx 57 M Geisert
177 R4505E KO C57BL/6J-Rpe65 57 F Geisert
178 R4506E KO C57BL/6J-Rpe65 57 F Geisert
179 R4535E GDP C57BLKS/J 66 F JAX
180 R4536E GDP C57BLKS/J 66 M JAX
181 R2564E.1 GDP CAST/EiJ 64 F JAX
182 R2580E.1 GDP CAST/EiJ 64 M JAX
183 R4537E GDP CBA/CaJ 66 F JAX
184 R4538E GDP CBA/CaJ 66 M JAX
185 R4539E GDP CZECHII/EiJ 66 F JAX
186 R4540E GDP CZECHII/EiJ 66 M JAX
187 R2600E.1 GDP BXD D2B6F1 72 F UTHSC RW
188 R2604E.1 GDP BXD D2B6F1 69 M UTHSC RW
189 R1002E.3 GDP BXD DBA/2J 72 F UTHSC RW
190 R4541E GDP BXD DBA/2J 65 F JAX
191 R959E.3 GDP BXD DBA/2J 60 M UTHSC RW
192 R2572E.1 GDP BXD DBA/2J 65 M UTHSC RW
193 R4542E GDP BXD DBA/2J 59 M JAX
194 R2771E.3 GDP FVB/NJ 60 F BIDMC GR
195 R2772E.3 GDP FVB/NJ 60 M BIDMC GR
196 R2636E.1 GDP KK/HlJ 64 F UTHSC RW
197 R2637E.1 GDP KK/HlJ 64 M UTHSC RW
198 R0999E.1 GDP LG/J 57 F UTHSC RW
199 R1004E.1 GDP LG/J 65 M UTHSC RW
200 R4543E GDP LP/J 65 F JAX
201 R4544E GDP LP/J 65 M JAX
202 R2858E.3 GDP MOLF/EiJ 60 F BIDMC GR
203 R2919.3 GDP MOLF/EiJ 60 M BIDMC GR
204 R1688E.1 GDP NOD/LtJ 66 F JAX
205 R2566E-2.1 GDP NOD/LtJ 76 M UTHSC RW
206 R4545E GDP NZB/BlNJ 61 F BIDMC GR
207 R4546E GDP NZB/BlNJ 58 M BIDMC GR
208 R2535E.1 GDP NZO/HlLtJ 62 F JAX
209 R2550E.1 GDP NZO/HlLtJ 96 M JAX
210 R2817E.3 GDP NZW/LacJ 65 F BIDMC GR
211 R2810E GDP NZW/LacJ 60 M BIDMC GR
212 R2810E.3 GDP NZW/LacJ 60 M BIDMC GR
213 R4547E GDP PANCEVO/EiJ 68 F JAX
214 R4548E GDP PANCEVO/EiJ 68 M JAX
215 R2635E.1 GDP PWD/PhJ 62 F JAX
216 R2634E.1 GDP PWD/PhJ 62 M JAX
217 R2544E.1 GDP PWK/PhJ 63 F JAX
218 R2549E.1 GDP PWK/PhJ 83 M JAX
219 R4550E GDP SJL/J 65 M+F JAX
220 R2368E.1 GDP WSB/EiJ 67 F UTHSC RW
221 R2547E.1 GDP WSB/EiJ 67 M UTHSC RW


About the array platform:

Affymetrix Mouse Genome 430 2.0 arrays: The 430 2.0 array consists of 992936 25-nucleotide probes that estimate the expression of approximately 39,000 transcripts (many probes overlap and target the same transcript). The array sequences were selected late in 2002 using Unigene Build 107. The array nominally contains the same probe sequences as the old M430A and 430B array pair. However, we have found that roughy 75000 probes differ between those on A and B arrays and those on the new 430 2.0.

As part of the development of HEIMED, we have manually annotated individual probe sets by sequence alignment to the mouse genome and transcriptome. Approximately 13,000 probe sets that have comparatively high expression in eye and CNS were curated by one of the authors (RWW) and now have specific information on the part of the transcript targeted by each probe set. The other 33,000 transcripts have corresponding data that was generated by Xusheng Wang using computational methods (BLAT analysis combined with annotated genome sequence).

One example may help explain how to exploit this annotation. The four probe sets for rhodopsin include information on the target location. Only the first probe set targets the last two coding exons. The other three probe sets target different parts of the 3’ UTR (mid, distal, and far distal regions). The probe sets can be reordered by from high to low expression using the Sort By function in Search Results pages. In the case of rhodopsin, the probe set that targets that last two coding exons and proximal parts of the 3’ UTR also has the highest expression . Finally, the HEIMED gene descriptions have been customized to help vision researchers. In the case of rhodopsin, the description appended after the gene name reads “rod photoreceptor pigment, retinitis pigmentosa-associated”. For less well known genes this kind of annotation can be extremely useful. For example, the more verbose annotation for Cerkl reads “neuronal survival and apoptosis-related, retinal ganglion cell expressed, retinitis pigmentosa 26); alternative 3' UTR of short form message, intron 2”.

 

Legend: Distribution of expression values for all probe sets in HEIMED.



About data values and data processing:

Range of Gene Expression in the Eye. Expression of transcripts in the HEIMED and most other GN data sets is measured on a log2 scale. Each unit corresponding approximately to a 2-fold difference in hybridization signal intensity. To simplify comparisons among different data sets and cases, log2 RMA values of each array have been adjusted to an average expression of 8 units and a standard deviation of 2 units (variance stabilized). Values of all 45,101 probe sets in this data set range from a low of 4.8 (Tcf15, probe set 1420281_at) to a high of 15.5 (crystallin gamma C, Crygc, probe set 1422674_s_at). This corresponds to 10.7 units or a 1 to 1700 dynamic range of expression (2^10.73).

We used pooled RNA samples of whole eyes, usually two independent pools--one male, one female pool--for most lines of mice. This data set was processed using the RMA protocol. A total of 2223 probes sets are associated with LRS values greater than 46 (LOD >10).

We calibrated this log intensity scale using Affymetrix spike-in control probe sets. These 18 control probe sets target exogenous bacterial mRNAs that are added to each sample (a graded dose spike cocktail) during preparation at concentrations of 1.5, 5, 25, and 100 pM. (To find these probe sets, search GN’s ALL search field using the string “AFFX pM”.) A value of 6 or less is equivalent to an mRNA concentration of under 0.4 pM, a value of 8 is equivalent to ~1.5 pM, 9.5 is equivalent to ~5 pM, 11.5 is equivalent to ~25 pM, 13.5 is equivalent to ~100 pM, and a value of 15.5 is equivalent to an mRNA concentration of 400 pM or greater.

This range can be converted to the mRNA molecules per cell in the eye assuming that a value of 8 is equivalent to about 1 mRNA copy per cell (Kanno et al. 2006, see http://www.biomedcentral.com/1471-2164/7/64). Since the expression of rhodopsin mRNA is normally 15 units, we predict that there are 27 or ~128 Rho mRNAs per cell in the whole eye and ~256 in rods themselves (assuming that rods make up about half of all cells in the eye). For this purpose it may be useful to know that a normal mouse eye contains between 6 and 8 million rod photoreceptors (Guo, Lu, and Williams; GN BXD Phenotype ID 11024).

Note that some probe sets with very low expression still provide reliable data. For example, probe set 1440397_at (Cacna2d1) has expression of only 5.5 units (a value that would be declared as "absent" using conventional Affymetrix procedures), but the values for this calcium channel transcript are associated with a very strong cis QTL with an LRS of 79 (LOD = 17). This strong linkage is definitely not due to chance since the probability of the expression data mapping precisely to the location of the parent gene itself is about 10e-16. This indicates a high signal to noise ratio and the detection of significant strain variation of the correct transcript.

The standard error of the mean for the HEIMED data set is computed for 2 to 6 biological replicates. The standard error of such small samples tends to systematically underestimate the population standard error. With n = 2 the underestimate is about 25%, whereas for n = 6 the underestimate is 5%. Gurland and Tripathi (1971) provide a correction and equation for this effect (see Sokal and Rohlf, Biometry, 2nd ed., 1981, p 53 for an equation of the correction factor for small samples of n < 20.) Probe (cell) level data from the CEL file: These CEL values produced by GCOS are 75% quantiles from a set of 91 pixel values per cell. The CEL files were processed using the RMA protocol. We processed the first three batches together. The last batch was processed separately and merged as described below.

  • Step 1: We added an offset of 1.0 unit to each cell signal to ensure that all values could be logged without generating negative values. We then computed the log base 2 of each cell.
  • Step 2: We performed a quantile normalization of the log base 2 values for the total set of arrays using the same initial steps used by the RMA transform.
  • Step 3: We computed the Z scores for each cell value.
  • Step 4: We multiplied all Z scores by 2.
  • Step 5: We added 8 to the value of all Z scores. The consequence of this simple set of transformations is to produce a set of Z scores that have a mean of 8, a variance of 4, and a standard deviation of 2. The advantage of this modified Z score is that a two-fold difference in expression level corresponds approximately to a 1 unit difference.
  • Step 6: Finally, when appropriate, we computed the arithmetic mean of the values for the set of microarrays for each strain. Technical replicates were averaged before computing the mean for independent biological samples.

After RMA processing using Biobase affy10 build running under R version 2.7.1, all array data sets were rank-order normalized. This second round of quantile normalization removes much residual non-linearity across arrays and forces every array to have the same distribution of values as the mean of all arrays. Comparative array data quality was then evaluated in DataDesk. Outlier arrays were flagged by visual inspection in DataDesk, usually by means of an analysis of scatter plots and more quantitatively by generating a correlation matrix of all arrays. Those arrays with mean correlation <0.96 versus all other arrays indicates trouble or a biological outlier). In some cases, outliers were expected, such as samples from strains with retinal degeneration (FVB/NJ, NOD/LtJ, MOLF/EiJ, C3H/HeJ and BXD24), samples from wild subspecies such as WSB/EiJ, CAST/EiJ, PWD/PhJ, and PWK/PhJ, and knockouts. However, when arrays were anomolous both within strain and across strains, they were often simply discarded. The assumption is that anomolous data are much more likely due to experimental and technical errors than to informative biological variation. Approximately 10% of arrays were discarded.

After this process, the acceptable set of arrays was renormalized using all step as above, starting with the original RMA procedure, etc.

We reviewed the data set using a new method developed by RW Williams, Jeremy Peirce, and Hongqiang Li. For the full set of arrays that passed standard QC protocols described above, we computed the strain means for the BXD strains, B6, D2, and F1s. Using this set of strain means we then computed LRS scores for all 45101 probe sets and counted the number of transcripts that generated QTLs with LRS values greater than 50. This value (e.g., 1800) represented the QTL harvest for the full data set. We then dropped a single array from the data set, recomputed strain means, and recomputed the number of transcripts with LRS scores great than 50. This value is expected to typically reduce the number of QTLs that reach the criterion level (e.g., 1750 QTLs > 50). This process was repeated for every array to obtain an array-specific difference value--the effect of removing that array on the total QTL count. For example, the loss of a single array might cause a decrease in 50 QTLs. Values ranged from approximately -90 (good arrays) to +40 (bad arrays). This procedure is similar in some ways to a jackknife protocol, although we are not using this procedure to esimate an error term, but rather as a method to polish a data set.

During this process we discovered that nearly 20 arrays in the batch 2 had been mislabeled at some point in processing. We computed the correct strain membership of each array using a large number of Mendelian probe sets (more than 50) and comparing their match to standard SNP and microsatellite markers and the original array data set of November 2005. This allowed us to rescue a large number of arrays that were of high quality.

A third batch of approximately 40 arrays were processed by Yan Jiao and Weikuan Gu in August 2006. These complete data set assembled by Hongqiang Li. This process again included a correction for a batch effect.

For the June 2006 data set Hongqiang Li used a new batch correction method that stabilizes the range of expression in each batch. For each of the three large batches, we extracted the minumum and maximum raw probe expression (CEL file level) value. We then adjusted raw probe values in each batch to have the same range as the first and largest batch (batch 1) using a simple linear interpolation. These procedures generated new correct CEL files which were then used with RMA to generate final probe set estimates.

For the final fourth batch of arrays (Sept 2008) Arthur Centeno and Rob Williams corrected for a systematic difference in probe set expression values between original arrays run in 2005 and 2006 and the new arrays added in 2008 (n = 45 acceptable arrays). This difference is due to unknown technical batch effects that are probably associated with labeling, hybridization, and scanning. We performed a simple correction to normalize values of the new set of arrays to those of the old set (batches 1 through 3). No changes were made to any values of the previous three batches. We corrected only the probe set level (RMA) values and not the CEL files. For this final batch, we corrected for the difference (offset) in probe set expression between the first three batches arrays run in 2005 and 2006 (a total of 174 acceptable arrays) and the new batch (n = 47 acceptable arrays). This difference is due to unknown technical effects that are probably related to various steps in labeling, hybridization, and scanning. The correction was applied as follows: (1) RWW selected 51 high quality arrays with similar expression characteristics (r = 0.97 or better between pairs of arrays) in the old data set (from batches 1, 2, and 3) and 34 high quality arrays in the final batch. RWW used scatterplots of full RMA transcriptome data sets to review many pairs of arrays within these new and old array batches. Strains with retinal degeneration or unusual eye gene expression characteristics were excluded from these selected subsets. The average expression values for each probe set were then computed for both the old and new array subsets. The offset value (old minus new) was added to each probe set across all 47 new arrays. This processes forces the average probe set in the new arrays to be very close to that of the previous arrays.

Table 2: Sample tube ID, strain, original CEL filename, and Affymetrix quality control values. Columns labeled Scale factor, Background Average, Present, Absent, Marginal and 3'/5' ratios for actin and Gapdh were collated from the Affymetrix Report (RPT) files.

 

Index TubeID Strain Original CEL Scale factor Background Average Present Absent Marginal AFFX-b-ActinMur (3'/5') AFFX-GapdhMur (3'/5') Batch Id Used for batch control
1 R2595E.1 129S1/SvImJ R2595E.1.CEL 1.79 115 61.00% 37.50% 1.50% 1.46 0.77 1 Y
2 R2533E.1 129S1/SvImJ R2533E.1.CEL 2.11 94 57.90% 40.50% 1.60% 1.37 0.78 1 Y
3 R0754E.1 A/J R0754E.1.CEL 2.72 86 59.80% 38.70% 1.50% 1.36 0.76 1 Y
4 R4521E B6129P2F2N1-Clcn3 R4521E.CEL 4.83 38.7 63.30% 35.30% 1.40% 1.25 0.77 4  
5 R4522E B6129P2F2N1-Clcn3 R4522E.CEL 5.76 37.36 62.90% 35.70% 1.40% 1.37 0.83 4  
6 R4523E B6129P2F2N1-Clcn3 R4523E.CEL 4.88 40.42 63.90% 34.70% 1.40% 1.27 0.77 4  
7 R4526E B6129P2F2N1-Gabbr1 R4526E.CEL 3.84 44.18 65.00% 33.70% 1.30% 1.34 0.78 4 Y
8 R4509E B6129P2F2N1-Gabbr1 R4509E.CEL 7.45 34.76 58.90% 39.70% 1.40% 1.45 0.83 4  
9 R4510E B6129P2F2N1-Gabbr1 R4510E.CEL 8.44 37.44 57.40% 41.10% 1.50% 1.35 0.83 4  
10 R4511E B6129P2F2N1-Gabbr1 R4511E.CEL 5.91 42.02 61.40% 37.20% 1.40% 1.41 0.83 4  
11 R4524E B6129P2F2N1-Gabbr1 R4524E.CEL 5.49 42.34 62.40% 36.20% 1.40% 1.29 0.78 4 Y
12 R4525E B6129P2F2N1-Gabbr1 R4525E.CEL 4.69 41.3 63.10% 35.50% 1.40% 1.27 0.8 4 Y
13 R4515E B6129P2F2N1-Gabra1 R4515E.CEL 5.75 41.76 62.80% 35.80% 1.40% 1.41 0.81 4 Y
14 R4516E B6129P2F2N1-Gabra1 R4516E.CEL 7.07 40.73 60.20% 38.40% 1.40% 1.32 0.87 4 Y
15 R4517E B6129P2F2N1-Gabra1 R4517E.CEL 5.45 38.09 62.70% 35.80% 1.40% 1.34 0.82 4 Y
16 R4512E B6129P2F2N1-Gnb5 R4512E.CEL 6.56 38.02 59.90% 38.70% 1.50% 1.33 0.83 4  
17 R4513E B6129P2F2N1-Gnb5 R4513E.CEL 4.15 41.6 63.40% 35.10% 1.50% 1.34 0.82 4  
18 R4514E B6129P2F2N1-Gnb5 R4514E.CEL 5.86 39.2 61.20% 37.30% 1.50% 1.34 0.81 4  
19 R4518E B6129P2F2N1-Gpr19 R4518E.CEL 5.58 38.9 62.60% 36.00% 1.30% 1.39 0.79 4 Y
20 R4519E B6129P2F2N1-Gpr19 R4519E.CEL 5.95 41.91 61.30% 37.30% 1.40% 1.35 0.84 4 Y
21 R2601E.1 B6D2F1 R2601E.1.CEL 2.55 92 58.90% 39.60% 1.50% 1.44 0.78 1 Y
22 R2602E.1 B6D2F1 R2602E.1.CEL 2.6 84 59.70% 38.80% 1.50% 1.37 0.78 1 Y
23 R1676E.1 BALB/cByJ R1676E.1.CEL 2.69 98 58.90% 39.60% 1.50% 1.46 0.74 1  
24 R1672E.1 BALB/cByJ R1672E.1.CEL 2.22 111 59.90% 38.60% 1.50% 1.26 0.8 1 Y
25 R4530E BALB/cJ R4530E.CEL 6.37 37.53 60.80% 37.80% 1.40% 1.3 0.84 4 Y
26 R4529E BALB/cJ R4529E.CEL 5.71 41.33 60.50% 38.00% 1.50% 1.48 0.8 4 Y
27 R2704E.2 BXD1 R2704E.2.CEL 2.066 139.61 56.60% 41.90% 1.50% 1.31 0.81 2  
28 R2707E.3 BXD1 R2707E.3.CEL 1 80 56.40% 42.10% 1.50% 1.43 0.79 3  
29 R1231E.2 BXD2 R1231E.2.CEL 2.197 138.73 57.30% 41.30% 1.40% 1.41 0.77 2  
30 R2598E.1 BXD2 R2598E.1.CEL 1.99 106 60.90% 37.60% 1.50% 1.27 0.78 1 Y
31 R2591E.1 BXD5 R2591E.1.CEL 1.7 136 58.50% 40.00% 1.50% 1.33 0.78 1 Y
32 R2714E.2 BXD5 R2714E.2.CEL 1.404 144.35 60.60% 37.90% 1.50% 1.43 0.79 2  
33 R2570E.1 BXD6 R2570E.1.CEL 1.99 87 58.50% 40.00% 1.50% 1.46 0.76 1 Y
34 R2694E.2 BXD6 R2694E.2.CEL 1.983 97.23 61.60% 37.10% 1.30% 1.39 0.82 2  
35 R2538E.1 BXD8 R2538E.1.CEL 1.91 102 61.20% 37.30% 1.50% 1.52 0.79 1 Y
36 R2709E.2 BXD8 R2709E.2.CEL 1.99 99.79 60.90% 37.60% 1.50% 1.42 0.76 2  
37 R2708E.2 BXD9 R2708E.2.CEL 1.966 126.46 57.70% 40.70% 1.50% 1.4 0.84 2  
38 R2569E.1 BXD9 R2569E.1.CEL 1.75 87 55.10% 43.40% 1.50% 2.82 3.14 1  
39 R2581E.1 BXD11 R2581E.1.CEL 1.94 89 62.10% 36.40% 1.60% 1.55 0.81 1 Y
40 R2612E.2 BXD11 R2612E.2.CEL 1.83 142.03 58.20% 40.50% 1.40% 1.78 0.81 2  
41 R2742E.2 BXD12 R2742E.2.CEL 2.127 134.14 57.00% 41.60% 1.40% 1.64 0.78 2  
42 R2543E.1 BXD12 R2543E.1.CEL 1.61 118 58.60% 39.90% 1.60% 1.43 0.77 1 Y
43 R2586E.1 BXD13 R2586E.1.CEL 2.01 74 56.40% 42.00% 1.60% 2.85 3.81 1  
44 R877E.2 BXD13 R877E.2.CEL 1.558 125.63 61.20% 37.50% 1.20% 1.42 0.81 2  
45 R2557E.1 BXD14 R2557E.1.CEL 1.83 99 62.50% 36.10% 1.40% 1.31 0.78 1 Y
46 R1128E.2 BXD14 R1128E.2.CEL 1.91 115 59.90% 38.80% 1.40% 1.2 0.82 1 Y
47 R2701E.3 BXD15 R2701E.3.CEL 1 88 60.60% 37.90% 1.40% 1.5 0.77 3  
48 R2716E.2 BXD15 R2716E.2.CEL 2.015 150.83 56.40% 42.10% 1.60% 1.42 0.81 2  
49 R2711E.2 BXD16 R2711E.2.CEL 1.953 118.53 59.00% 39.60% 1.50% 1.45 0.8 2  
50 R2567E.1 BXD16 R2567E.1.CEL 2.24 82 56.70% 41.60% 1.70% 1.37 0.75 1  
51 R2720E.2 BXD18 R2720E.2.CEL 2.32 99.93 59.50% 39.00% 1.50% 1.33 0.77 2  
52 R2559E.1 BXD18 R2559E.1.CEL 1.65 104 60.80% 37.70% 1.50% 1.27 0.78 1 Y
53 R2560E.1 BXD19 R2560E.1.CEL 1.79 98 60.90% 37.50% 1.60% 1.35 0.8 1 Y
54 R2713E.2 BXD19 R2713E.2.CEL 1.67 120.82 60.20% 38.30% 1.50% 1.45 0.8 2  
55 R2584E.1 BXD20 R2584E.1.CEL 2.07 84 59.30% 39.10% 1.60% 1.4 0.76 1 Y
56 R2731E.2 BXD20 R2731E.2.CEL 1.825 147 59.00% 39.50% 1.50% 1.4 0.8 2  
57 R2702E.2 BXD21 R2702E.2.CEL 1.811 128.65 59.40% 39.10% 1.40% 1.26 0.8 2  
58 R2541E2.1 BXD21 R2541E2.1.CEL 2.63 125 56.00% 42.40% 1.50% 1.29 0.78 1  
59 R2553E.1 BXD22 R2553E.1.CEL 1.95 111 59.90% 38.50% 1.50% 1.28 0.76 1 Y
60 R2700E.2 BXD22 R2700E.2.CEL 1.858 102.96 61.50% 37.10% 1.30% 1.48 0.79 2  
61 R2558E-2.1 BXD23 R2558E-2.1.CEL 2.233 125.05 58.60% 39.90% 1.50% 1.43 0.77 2  
62 R1086E.2 BXD23 R1086E.2.CEL 2.233 125.05 58.60% 39.90% 1.50% 1.43 0.77 2  
63 R2719E.2 BXD24 R2719E.2.CEL 1.47 140.38 61.50% 37.20% 1.30% 1.38 0.79 2  
64 R2589E2.1 BXD24 R2589E2.1.CEL 2.61 112 57.50% 40.90% 1.60% 1.24 0.8 1  
65 R2573E-2.1 BXD25 R2573E-2.1.CEL 3.15 72 57.90% 40.70% 1.40% 1.77 0.97 1  
66 R2683E.2 BXD25 R2683E.2.CEL 1.777 115.64 58.30% 40.30% 1.40% 2.01 0.79 2  
67 R2703E.2 BXD27 R2703E.2.CEL 1.263 134.78 62.60% 36.10% 1.40% 1.44 0.78 2  
68 R2729E.3 BXD27 R2729E.3.CEL 1 87 57.90% 40.60% 1.50% 1.56 0.84 3 Y
69 R2562E.3 BXD28 R2562E.3.CEL 1.65 116 59.90% 38.40% 1.70% 1.37 0.79 3 Y
70 R2721E.2 BXD28 R2721E.2.CEL 2.065 157.39 56.10% 42.40% 1.50% 1.31 0.81 2  
71 R2561E.3 BXD29 R2561E.3.CEL 1 77 53.30% 45.40% 1.40% 3.36 19.66 3  
72 R1258E.2 BXD31 R1258E.2.CEL 2.063 117.09 59.00% 39.50% 1.50% 1.54 0.78 2  
73 R2597E.1 BXD31 R2597E.1.CEL 2.37 94 60.30% 38.30% 1.50% 1.34 0.77 1 Y
74 R2563E.1 BXD32 R2563E.1.CEL 1.55 102 61.90% 36.70% 1.40% 1.5 0.8 1  
75 R1216E.2 BXD32 R1216E.2.CEL 2.23 111.99 58.80% 39.80% 1.40% 1.35 0.79 2  
76 R2542E.1 BXD33 R2542E.1.CEL 2.13 97 56.50% 41.80% 1.60% 1.91 0.93 1  
77 R857E.2 BXD33 R857E.2.CEL 1.737 113.98 61.90% 36.70% 1.30% 1.6 0.77 2  
78 R1451E.2 BXD34 R1451E.2.CEL 1.843 140.05 59.00% 39.50% 1.50% 1.42 0.81 2 Y
79 R2585E.1 BXD34 R2585E.1.CEL 2.64 75 58.30% 40.00% 1.70% 1.25 0.77 1  
80 R2698E.3 BXD36 R2698E.3.CEL 1 86 59.70% 39.00% 1.30% 1.46 0.78 3  
81 R2705E.3 BXD36 R2705E.3.CEL 1 86 60.20% 38.40% 1.40% 1.46 0.77 3  
82 R2710E.2 BXD38 R2710E.2.CEL 2.112 122.1 58.80% 39.80% 1.40% 1.37 0.78 2  
83 R2532E.1 BXD38 R2532E.1.CEL 2.04 94 59.80% 38.70% 1.50% 1.37 0.8 1 Y
84 R2574E.1 BXD39 R2574E.1.CEL 1.98 91 61.20% 37.30% 1.50% 1.39 0.78 1  
85 R2695E.2 BXD39 R2695E.2.CEL 1.638 122.7 60.80% 37.80% 1.50% 1.42 0.8 2  
86 R2699E.2 BXD40 R2699E.2.CEL 1.827 105.23 61.70% 36.90% 1.40% 1.42 0.81 2  
87 R2590E.1 BXD40 R2590E.1.CEL 2.71 77 59.10% 39.30% 1.50% 1.4 0.77 1 Y
88 R2696E.2 BXD42 R2696E.2.CEL 1.622 118.95 62.00% 36.60% 1.50% 1.53 0.79 2  
89 R2596E.1 BXD42 R2596E.1.CEL 2.63 108 59.00% 39.60% 1.50% 1.24 0.8 1  
90 R994E.2 BXD43 R994E.2.CEL 1.966 113.12 60.80% 37.80% 1.40% 1.66 0.8 2  
91 R2607E.1 BXD43 R2607E.1.CEL 2.43 115 58.60% 40.00% 1.40% 1.31 0.76 1 Y
92 R2594E.1 BXD44 R2594E.1.CEL 1.77 117 59.80% 38.80% 1.40% 1.35 0.85 1  
93 R2610E.2 BXD44 R2610E.2.CEL 1.814 142.91 59.00% 39.50% 1.50% 1.35 0.8 2  
94 R2732E.2 BXD45 R2732E.2.CEL 2.154 122.45 56.50% 42.10% 1.40% 1.8 0.83 2  
95 R2592E.1 BXD45 R2592E.1.CEL 1.85 106 60.10% 38.60% 1.30% 1.43 0.85 1 Y
96 R967E.2 BXD48 R967E.2.CEL 1.948 130.95 57.30% 41.20% 1.50% 1.63 0.81 2  
97 R2606E.1 BXD48 R2606E.1.CEL 2.56 106 58.90% 39.70% 1.40% 1.35 0.83 1 Y
98 R2933E.3 BXD50 R2933E.3.CEL 1 72 52.90% 45.60% 1.50% 2.45 0.98 3  
99 R2937E.3 BXD50 R2937E.3.CEL 1 89 56.90% 41.60% 1.40% 1.81 0.82 3  
100 R2603E.1 BXD51 R2603E.1.CEL 2.49 115 57.70% 40.80% 1.50% 1.24 0.79 1  
101 R1042E.2 BXD51 R1042E.2.CEL 2.352 104.12 58.70% 39.90% 1.40% 1.53 0.82 2  
102 R2980E.3 BXD55 R2980E.3.CEL 1 82 56.90% 41.70% 1.50% 1.77 0.84 3  
103 R2690E.2 BXD55 R2690E.2.CEL 1.887 164.01 56.10% 42.30% 1.60% 1.43 0.8 2  
104 R4176E BXD56 R4176E.CEL 4.75 43.08 63.00% 35.60% 1.30% 1.39 0.81 4 Y
105 R4175E BXD56 R4175E.CEL 6 38.49 61.30% 37.30% 1.40% 1.47 0.81 4 Y
106 R1006E.3 BXD60 R1006E.3.CEL 1 98 54.90% 43.70% 1.50% 2.7 0.86 3  
107 R2725E.2 BXD60 R2725E.2.CEL 1.551 148.01 59.80% 38.80% 1.40% 1.43 0.79 2  
108 R1074E.3 BXD60 R1074E.3.CEL 1 118 55.50% 43.10% 1.40% 1.96 0.81 3  
109 R2534E2.1 BXD61 R2534E2.1.CEL 2.47 118 57.90% 40.60% 1.50% 1.42 0.79 1  
110 R2684E.2 BXD61 R2684E.2.CEL 2.01 131.03 57.00% 41.50% 1.50% 1.34 0.78 2  
111 R1107E.3 BXD62 R1107E.3.CEL 1 83 55.20% 43.40% 1.40% 2.43 0.93 3  
112 R2681E.2 BXD62 R2681E.2.CEL 2.086 148.24 57.20% 41.30% 1.50% 1.29 0.81 2  
113 R965E.3 BXD62 R965E.3.CEL 1 93.55 53.30% 45.20% 1.50% 3.11 0.94 3  
114 R1425E.2 BXD63 R1425E.2.CEL 1.7 136 59.30% 39.30% 1.40% 1.43 0.82 2  
115 R2576E.3 BXD63 R2576E.3.CEL 1 84 61.30% 37.40% 1.40% 1.48 0.76 3  
116 R943E-2.2 BXD64 R943E-2.2.CEL 1.591 141.34 60.10% 38.40% 1.50% 1.32 0.76 2  
117 R2611E.1 BXD64 R2611E.1.CEL 2.29 92 58.00% 40.50% 1.50% 1.57 1.06 1  
118 R2689E.2 BXD65 R2689E.2.CEL 1.721 142.44 59.90% 38.60% 1.50% 1.38 0.76 2  
119 R2583E.1 BXD65 R2583E.1.CEL 2.49 70 56.90% 41.50% 1.60% 1.67 1.01 1  
120 R2728E.2 BXD66 R2728E.2.CEL 1.714 137.45 59.40% 39.00% 1.60% 1.38 0.79 2  
121 R2536E2.1 BXD66 R2536E2.1.CEL 2.74 109 56.10% 42.30% 1.70% 1.28 0.79 1  
122 R1207E.2 BXD66 R1207E.2.CEL 1.681 136.86 60.40% 38.10% 1.50% 1.45 0.77 2  
123 R1192E.2 BXD67 R1192E.2.CEL 2.126 123.37 57.90% 40.60% 1.50% 1.5 0.8 2  
124 R2727E.3 BXD67 R2727E.3.CEL 1 82.55 56.10% 42.40% 1.50% 1.97 0.87 2  
125 R2691E.3 BXD67 R2691E.3.CEL 1 90 54.80% 43.80% 1.50% 2.61 0.81 3  
126 R2551E.1 BXD68 R2551E.1.CEL 2.49 92 54.30% 44.10% 1.60% 2.91 1.55 1  
127 R2726E.2 BXD68 R2726E.2.CEL 1.811 153.09 58.70% 39.80% 1.50% 1.39 0.78 2  
128 R2593E.1 BXD69 R2593E.1.CEL 1.67 128 59.20% 39.50% 1.30% 1.47 0.92 1 Y
129 R975E.2 BXD70 R975E.2.CEL 1.841 137.97 58.00% 40.50% 1.40% 1.36 0.79 2  
130 R2537E2.1 BXD70 R2537E2.1.CEL 2.93 99 58.00% 40.50% 1.60% 1.29 0.75 1  
131 R4531E BXD71 R4531E.CEL 4.77 43.48 62.40% 36.30% 1.40% 1.23 0.77 4 Y
132 R4532E BXD71 R4532E.CEL 5.89 40.68 60.90% 37.60% 1.50% 1.24 0.79 4 Y
133 R2779E.2 BXD73 R2779E.2.CEL 1.746 121.11 59.60% 39.00% 1.40% 1.5 0.8 2  
134 R3024E.3 BXD73 R3024E.3.CEL 1 78.05 51.70% 46.60% 1.70% 2.3 0.94 3  
135 R2565E.1 BXD75 R2565E.1.CEL 1.79 102 58.00% 40.50% 1.50% 2.31 3.47 1  
136 R1397E-re.2 BXD75 R1397E-re.2.CEL 1.449 189.71 59.60% 39.00% 1.40% 1.39 0.82 2  
137 R2687E.3 BXD77 R2687E.3.CEL 1 80 58.00% 40.60% 1.40% 1.57 0.8 3 Y
138 R2717E.2 BXD77 R2717E.2.CEL 1.797 84.43 61.60% 36.90% 1.40% 1.49 0.76 2  
139 R1421E.3 BXD77 R1421E.3.CEL 1 94 52.40% 46.20% 1.40% 2.29 0.82 3  
140 R2579E.1 BXD80 R2579E.1.CEL 2.42 72 59.20% 39.40% 1.50% 1.73 0.82 1  
141 R2686E.2 BXD80 R2686E.2.CEL 2.342 119.63 56.00% 42.60% 1.50% 1.38 0.79 2  
142 R2956E.3 BXD83 R2956E.3.CEL 1 84 55.40% 43.20% 1.40% 1.39 0.84 3  
143 R2960E.3 BXD83 R2960E.3.CEL 1 80 56.60% 41.90% 1.50% 1.5 0.82 3 Y
144 R2922E.3 BXD84 R2922E.3.CEL 1 91 57.80% 40.80% 1.50% 1.47 0.83 3 Y
145 R2895E.3 BXD84 R2895E.3.CEL 1 75 58.30% 40.20% 1.50% 1.56 0.77 3 Y
146 R2692E.2 BXD85 R2692E.2.CEL 1.423 160.87 60.20% 38.30% 1.40% 1.46 0.79 2  
147 R2715E.2 BXD85 R2715E.2.CEL 1.488 142.6 61.20% 37.30% 1.40% 1.5 0.78 2  
148 R1405E.2 BXD86 R1405E.2.CEL 2.351 119.34 56.40% 42.20% 1.40% 1.64 0.81 2  
149 R1225E.3 BXD86 R1225E.3.CEL 1 71 53.90% 44.60% 1.40% 3.2 1.61 3  
150 R2724E.2 BXD87 R2724E.2.CEL 1.906 113.71 60.70% 37.90% 1.40% 1.45 0.79 2  
151 R2540E.1 BXD87 R2540E.1.CEL 2.33 93 61.10% 37.40% 1.40% 1.22 0.81 1 Y
152 R1433E.2 BXD89 R1433E.2.CEL 1 2.241 57.70% 40.80% 1.50% 1.41 0.78 2  
153 R2546E.1 BXD89 R2546E.1.CEL 1.99 96 58.60% 39.70% 1.70% 1.47 0.78 1  
154 R2578E2.1 BXD90 R2578E2.1.CEL 2.79 92 58.60% 39.80% 1.60% 1.52 0.77 1 Y
155 R859E.2 BXD90 R859E.2.CEL 1.847 152.22 57.90% 40.70% 1.40% 1.36 0.77 2  
156 R2682E.2 BXD92 R2682E.2.CEL 1.547 156.31 60.40% 38.20% 1.40% 1.37 0.77 2  
157 R1388E.3 BXD92 R1388E.3.CEL 1 63 60.00% 38.60% 1.40% 1.85 1.03 3  
158 R1322E.3 BXD92 R1322E.3.CEL 1 80 55.90% 42.60% 1.50% 1.75 0.74 3  
159 R2733E.2 BXD96 R2733E.2.CEL 1.7 113.99 62.10% 36.60% 1.30% 1.4 0.78 2  
160 R2554E.1 BXD96 R2554E.1.CEL 2.18 93 60.20% 38.30% 1.50% 1.46 0.77 1 Y
161 R2649E.2 BXD97 R2649E.2.CEL 2.343 119.04 57.50% 41.20% 1.40% 1.53 0.8 2  
162 R2577E.1 BXD97 R2577E.1.CEL 2.07 77 59.50% 39.10% 1.40% 1.87 1.29 1  
163 R2645E.3 BXD98 R2645E.3.CEL 1 88 59.40% 39.20% 1.50% 1.59 0.81 3 Y
164 R2688E.2 BXD98 R2688E.2.CEL 1.772 145.24 58.50% 40.00% 1.50% 1.48 0.81 2  
165 R4533E BXD99 R4533E.CEL 1 37.69 60.30% 38.20% 1.40% 1.33 0.89 4 Y
166 R4534E BXD99 R4534E.CEL 5.69 36.62 62.90% 35.70% 1.40% 1.16 0.8 4 Y
167 R2885E.3 BXSB/MpJ R2885E.3.CEL 1 76 58.10% 40.60% 1.30% 1.88 1.06 3  
168 R2883E.3 BXSB/MpJ R2883E.3.CEL 1 71 56.40% 42.00% 1.50% 1.59 0.84 3 Y
169 R1700E.1 C3H/HeJ R1700E.1.CEL 2.98 69 60.80% 37.90% 1.40% 1.48 0.78 1  
170 R1704E.1 C3H/HeJ R1704E.1.CEL 2.58 88 60.10% 38.60% 1.30% 1.38 0.84 1  
171 R2605E.1 C57BL/6J R2605E.1.CEL 1.82 131 60.50% 38.20% 1.30% 1.32 0.8 1 Y
172 R0871E C57BL/6J R0871E.CEL 6.24 37.38 61.90% 36.70% 1.40% 1.41 0.8 4 Y
173 R0872E.1 C57BL/6J R0872E.1.CEL 3.13 89 58.90% 39.60% 1.50% 1.3 0.79 1 Y
174 R0872E C57BL/6J R0872E.CEL 3.128 88.58 58.90% 39.60% 1.50% 1.3 0.79 1  
175 R4507E C57BL/6J-Nyx R4507E.CEL 8.13 37.5 59.30% 39.30% 1.40% 1.32 0.8 4 Y
176 R4508E C57BL/6J-Nyx R4508E.CEL 6.33 37.26 60.90% 37.80% 1.30% 1.24 0.82 4 Y
177 R4505E C57BL/6J-Rpe65 R4505E.CEL 5.98 37.48 61.80% 36.80% 1.40% 1.45 0.85 4 Y
178 R4506E C57BL/6J-Rpe65 R4506E.CEL 6.94 37.9 61.10% 37.50% 1.30% 1.5 0.83 4 Y
179 R4535E C57BLKS/J R4535E.CEL 6.59 37.28 61.20% 37.30% 1.40% 1.26 0.83 4 Y
180 R4536E C57BLKS/J R4536E.CEL 1 40.71 60.30% 38.20% 1.50% 1.25 0.77 4 Y
181 R2564E.1 CAST/EiJ R2564E.1.CEL 1.94 89 58.50% 39.90% 1.60% 1.6 0.77 1  
182 R2580E.1 CAST/EiJ R2580E.1.CEL 2.09 95 58.20% 40.10% 1.70% 1.4 0.76 1  
183 R4537E CBA/CaJ R4537E.CEL 1 38.45 60.60% 37.90% 1.50% 1.63 0.82 4 Y
184 R4538E CBA/CaJ R4538E.CEL 5.89 39.18 61.70% 36.90% 1.40% 1.45 0.8 4 Y
185 R4539E CZECHII/EiJ R4539E.CEL 7.73 37.1 58.30% 40.10% 1.50% 1.7 0.95 4 Y
186 R4540E CZECHII/EiJ R4540E.CEL 11.04 36.69 53.00% 45.30% 1.70% 1.83 1.32 4  
187 R2600E.1 D2B6F1 R2600E.1.CEL 2.47 95 58.10% 40.20% 1.70% 1.41 0.78 1 Y
188 R2604E.1 D2B6F1 R2604E.1.CEL 2.66 90 59.40% 39.20% 1.50% 1.28 0.79 1 Y
189 R1002E.3 DBA/2J R1002E.3.CEL 1 102 54.80% 43.70% 1.50% 2.84 0.83 3  
190 R4541E DBA/2J R4541E.CEL 1 43.4 61.40% 37.00% 1.50% 1.37 0.73 4 Y
191 R959E.3 DBA/2J R959E.3.CEL 1 89.97 53.20% 45.30% 1.50% 3.66 1.09 4  
192 R2572E.1 DBA/2J R2572E.1.CEL 2.41 79 55.50% 42.90% 1.60% 1.37 0.79 1  
193 R4542E DBA/2J R4542E.CEL 5.7 39.95 61.00% 37.40% 1.50% 1.23 0.81 4 Y
194 R2771E.3 FVB/NJ R2771E.3.CEL 1 70 55.30% 43.20% 1.50% 1.69 0.83 3  
195 R2772E.3 FVB/NJ R2772E.3.CEL 1 76 55.20% 43.40% 1.40% 2.13 1.02 3  
196 R2636E.1 KK/HlJ R2636E.1.CEL 2.61 93 58.90% 39.50% 1.50% 1.39 0.76 1 Y
197 R2637E.1 KK/HlJ R2637E.1.CEL 2.19 103 59.40% 39.00% 1.50% 1.3 0.79 1 Y
198 R0999E.1 LG/J R0999E.1.CEL 2.45 82 59.40% 39.10% 1.50% 1.38 0.79 1 Y
199 R1004E.1 LG/J R1004E.1.CEL 2.44 92 58.70% 39.80% 1.50% 1.38 0.79 1 Y
200 R4543E LP/J R4543E.CEL 6.57 41.99 60.30% 38.20% 1.50% 1.28 0.75 4 Y
201 R4544E LP/J R4544E.CEL 4.56 39.9 62.40% 36.10% 1.50% 1.23 0.77 4 Y
202 R2858E.3 MOLF/EiJ R2858E.3.CEL 1 64 53.80% 44.70% 1.50% 1.59 0.95 3  
203 R2919.3 MOLF/EiJ R2919.3.CEL 1 64 52.40% 46.00% 1.60% 2.15 1.07 3  
204 R1688E.1 NOD/LtJ R1688E.1.CEL 2.66 98 58.60% 39.90% 1.50% 1.26 0.8 1 Y
205 R2566E-2.1 NOD/LtJ R2566E-2.1.CEL 3.03 69 59.80% 38.80% 1.50% 1.38 0.75 1 Y
206 R4545E NZB/BlNJ R4545E.CEL 4.23 43.48 62.10% 36.40% 1.50% 1.33 0.76 4 Y
207 R4546E NZB/BlNJ R4546E.CEL 6.27 44.22 59.40% 39.10% 1.50% 1.17 0.82 4 Y
208 R2535E.1 NZO/HlLtJ R2535E.1.CEL 1.89 86 60.40% 38.20% 1.40% 1.41 0.85 1  
209 R2550E.1 NZO/HlLtJ R2550E.1.CEL 1.79 87 60.70% 37.80% 1.50% 1.52 0.82 1  
210 R2817E.3 NZW/LacJ R2817E.3.CEL 1 59 50.90% 47.60% 1.50% 3.59 1.48 3  
211 R2810E NZW/LacJ R2810E.CEL               3  
212 R2810E.3 NZW/LacJ R2810E.3.CEL 1 74 57.00% 41.70% 1.40% 2.15 1.03 4 Y
213 R4547E PANCEVO/EiJ R4547E.CEL 5.27 51.34 57.20% 41.10% 1.70% 1.7 0.83 4  
214 R4548E PANCEVO/EiJ R4548E.CEL 10.54 37.39 50.30% 48.00% 1.70% 1.68 1.09 4  
215 R2635E.1 PWD/PhJ R2635E.1.CEL 3.72 80 54.20% 44.10% 1.70% 1.53 0.85 1  
216 R2634E.1 PWD/PhJ R2634E.1.CEL 3.29 90 55.90% 42.50% 1.60% 1.57 0.81 1  
217 R2544E.1 PWK/PhJ R2544E.1.CEL 2.2 108 54.90% 43.50% 1.70% 1.36 0.82 1  
218 R2549E.1 PWK/PhJ R2549E.1.CEL 2.28 84 57.30% 41.20% 1.50% 1.57 0.83 1  
219 R4550E SJL/J R4550E.CEL 5.35 40.44 62.30% 36.20% 1.40% 1.24 0.79 4  
220 R2368E.1 WSB/EiJ R2368E.1.CEL 2.57 86 59.50% 39.10% 1.40% 1.29 0.74 1 Y
221 R2547E.1 WSB/EiJ R2547E.1.CEL 2.14 90 58.20% 40.10% 1.60% 1.32 0.77 1 Y


Notes:

This data set is available as a bulk download in several formats. The data are available as either strain means or the individual arrays. Due to the involved normalization procedures required to correct for batch effects we strongly recommend not using the raw CEL files without special statistical procedures.



Experiment Type:

Expression profiling by array



Contributor:

Eldon E. Geisert, Lu Lu, Natalie E. Freeman-Anderson, Xusheng Wang, Weikuan Gu, Yan Jiao, Robert W. Williams



Citation:

Eldon E. Geisert, Lu Lu, Natalie E. Freeman-Anderson, Xusheng Wang, Weikuan Gu, Yan Jiao, Robert W. Williams. Gene expression landscape of the mammalian eye: A global survey and database of mRNAs of 103 varieties of mice. Molecular Vision 2009; in press.



Data source acknowledgment:

Support for acquisition of microarray data sets was generously provided by Dr. Barrrett Haik, Chair of the Department of Ophthalmology, and director of the Hamilton Eye Institute. Support for the continued development of GeneNetwork was provided by a NIDA/NIMH/NIAAA Human Brain Project grant and from funds from NEI grant to Dr. Eldon Geisert (R01EY017841), an NEI Vision Core grant (EY14080) and an Unrestricted Grant from Research To Prevent Blindness.

We thank Dr. Ted Choi, Chief Scientific Director of Predictive Biology, Inc. (past director of molecular genetics at Deltagen Inc.) for providing us with eye samples from several interesting DeltaGen knockouts.



Study Id:
60

CITG WWW service initiated January, 1994 as The Portable Dictionary of the Mouse Genome and June 15, 2001 as WebQTL. This site is currently operated by Rob Williams, Pjotr Prins, Zachary Sloan, Arthur Centeno. Design and code by Pjotr Prins, Zach Sloan, Arthur Centeno, Danny Arends, Christian Fischer, Sam Ockman, Lei Yan, Xiaodong Zhou, Christian Fernandez, Ning Liu, Rudi Alberts, Elissa Chesler, Sujoy Roy, Evan G. Williams, Alexander G. Williams, Kenneth Manly, Jintao Wang, and Robert W. Williams, colleagues. Python Powered Registered with Nif
GeneNetwork support from:
  • The UT Center for Integrative and Translational Genomics
  • NIGMS Systems Genetics and Precision Medicine project (R01 GM123489, 2017-2021)
  • NIDA NIDA Core Center of Excellence in Transcriptomics, Systems Genetics, and the Addictome (P30 DA044223, 2017-2022)
  • NIA Translational Systems Genetics of Mitochondria, Metabolism, and Aging (R01AG043930, 2013-2018)
  • NIAAA Integrative Neuroscience Initiative on Alcoholism (U01 AA016662, U01 AA013499, U24 AA013513, U01 AA014425, 2006-2017)
  • NIDA, NIMH, and NIAAA (P20-DA 21131, 2001-2012)
  • NCI MMHCC (U01CA105417), NCRR, BIRN, (U24 RR021760)
    Join GeneNetwork Mailing List
    It took 0.054 second(s) for lily.uthsc.edu to generate this page